Peripheral Facial Palsy Prognosis

Interactive EMG assistant for Peripheral Facial Palsy: governed by the timeline of Wallerian degeneration, calculates the Axonal Viability Index (AVI), integrates Blink Reflex and needle EMG (21st day rule), and generates ready-to-use report sentences. For clinical use only.

The prognosis of peripheral facial palsy depends entirely on the temporal window: Wallerian degeneration is dynamic and the same finding (e.g., preserved CMAP) has opposite interpretations in the hyperacute phase vs. at the nadir. This calculator stratifies by phase, calculates the AVI when applicable (Golden Window days 6–10), and applies the needle EMG 21-day rule.

AVI = (Paralyzed side CMAP amplitude / Normal side CMAP amplitude) × 100 · Valid primarily between days 6 and 10 (loses value after ~day 21)

Group 1 - AVI > 50% · 3–4 months · neurapraxia
Group 2 - AVI 10–50% · 3–8 months · mixed lesion
Group 3 - AVI < 10% or Absent CMAP · 8–12+ months · synkinesis risk

Temporal Lock

In the hyperacute phase (days 1–5), CMAP may be falsely preserved even in complete nerve transection, as Wallerian degeneration is not yet complete. During this window, prognosis is based on the intracranial component (Blink R1 and, when available, motor cortex TMS) - never on isolated CMAP.

Step 1 - Initial Clinical Data

Etiology of facial palsy Traumatic etiology enables additional evaluation of voluntary MUPs during the hyperacute phase (after day 3).
Days since symptom onset Select a preset timeline range or enter the exact number of days - either will automatically select the evolutionary phase and relevant diagnostic questions.
or
Phase: -
Enter etiology and days post-onset to begin.

The Prognostic Timeline of Peripheral Facial Palsy – A Temporal Neurophysiological Approach

Determining the prognosis of peripheral facial palsy (PFP), particularly the idiopathic form (Bell's Palsy), is one of the greatest challenges in clinical neurophysiology. Diagnostic accuracy does not lie in a single miraculous test, but rather in choosing the indispensable and exact neurophysiological modality for each phase of Wallerian degeneration or reinnervation.

Introduction and Temporal Philosophy

Due to the long intratemporal course of the VII cranial nerve and the biology of Wallerian degeneration (which progresses from proximal to distal), the exact same electrical finding can have radically opposite interpretations depending on the evolutionary day. The clinical neurophysiologist acts as a true timekeeper, strictly applying the test indicated for each window.

1. Hyperacute Phase (24 to 48 hours / 1 to 2 days)

The pathological insult (edema, ischemia, or trauma) has just occurred in the intratemporal segment.

  • Indispensable Test: TMS (Transcranial Magnetic Stimulation): The only modality with early predictive value. Stimulation at the primary motor cortex and recording at the contralateral nasalis muscle. The presence of a motor response to TMS, even with reduced amplitude, indicates functional continuity and a favorable prognosis.
  • Inutility of CMAP and Needle EMG: Distal CMAP is invariably normal because Wallerian degeneration has not yet reached the face. Needle EMG is also useless, as there has not been enough time for spontaneous resting activity (fibrillations) to develop.

2. Initial Drop Phase and Traumatic Differentiation (Days 3 to 5)

Wallerian degeneration begins to manifest in the distal segment.

  • In Bell's Palsy: CMAP amplitude reduction begins to become evident during this window.
  • In Traumatic / Post-Surgical Palsy (Indispensable Test: Needle EMG): In direct extracranial or surgical lesions, degeneration occurs more rapidly. Searching for voluntary motor unit potentials (MUPs) on needle EMG dictates clinical management: the presence of any voluntary MUP proves a partial lesion (favorable prognosis, advising against urgent surgical exploration); total electrical silence associated with emerging spontaneous activity suggests severe nerve disruption (surgical exploration).

3. The Reflex Pathway Window (Days 6 to 10)

Critical period for overall assessment of nerve conduction.

  • Indispensable Test: Blink Reflex and Baseline CMAP: The Blink Reflex evaluates the entire pathway of the nerve. The presence of an R1 response (even with severely prolonged latency) is an explicitly favorable prognostic indicator.
  • Clinical Alert: An absent Blink Reflex with preserved CMAP is a warning sign of severe intracranial conduction block or incomplete Wallerian degeneration, requiring patient re-evaluation before day 14.
  • Technical Pearl (Unified Double Pulse Blink Reflex): When R1 is absent on single-pulse stimulation, paired-pulse stimulation (double pulse with an interval of ~5 ms) is applied. If a hidden R1 response reappears under double-pulse facilitation via subthreshold temporal summation, the prognosis immediately shifts to favorable! In our interface, this response is clearly unified: Present (single or double pulse) vs. Absent (including double pulse).

4. Axonal Nadir and Axonal Viability Index (Days 10 to 14)

Days 10 to 14 mark the nadir of CMAP amplitude in intratemporal lesions. Everything that was destined to degenerate has degenerated.

  • Indispensable Test: CMAP (Nasalis or Nasolabial Muscle): Recording at the nasalis muscle provides higher accuracy and reproducibility than orbicularis oculi (avoiding masseter volume conduction).
  • AVI Calculation (Uppsala / Stålberg): AVI = (Paralyzed CMAP / Normal CMAP) × 100.
    • Group 1 (AVI > 50%): Predominantly functional conduction block. Rapid and complete recovery in ~3 to 4 months.
    • Group 2 (AVI 10–50%): Mixed axon loss. Favorable recovery between 3 and 8 months.
    • Group 3 (AVI < 10%): Marked axonal loss. Slow and prolonged recovery (8 to 12+ months), with high risk of synkinesis.
  • Clinical Assessment (Days 12 to 14): In patients presenting with marked functional severity (absolute absence of Blink Reflex, absent CMAP, and electrical silence on needle EMG), close clinical correlation is recommended.

5. Intermediate and Transition Period (Days 15 to 20)

Transition window. Distal Wallerian degeneration stabilizes completely by day 21. Patients with an absent Blink Reflex on the day 10 evaluation must be re-evaluated during this window.

  • Indispensable Test: Blink Reflex Re-evaluation & AVI: If R1 persists absent between days 15 and 18, the probability of reversible conduction block drops drastically, confirming severe axon loss. AVI calculation remains valid before collateral sprouting begins.
  • Needle EMG Control: In idiopathic Bell's palsy, classic spontaneous activity is not yet exuberant during this window; postponing definitive prognostic needle examination to days 20–21 is recommended.

6. Denervation Confirmation Phase (Days 21 to 30)

After 3 weeks, Wallerian degeneration is complete and membrane instability in denervated muscle fibers reaches its peak.

  • Indispensable Test: Needle EMG (Resting Activity): This is the gold standard window for evaluating fibrillations (FIB) and positive sharp waves (PSWs).
  • Clinical Pearl (The 21-Day Rule): The absence of fibrillations at 21 days post-onset has ~100% sensitivity and ~90% specificity for excluding severe axonal lesion, confirming that axons maintained functional connection (favorable prognosis). Conversely, abundant denervation confirms structural axon loss.

7. Early Reinnervation Phase (1 to 3 Months)

Period in which collateral sprouting from surviving axons and axonal regeneration begin to reach facial musculature.

  • Indispensable Test: Needle EMG (Nascent MUPs): CMAP amplitude is unreliable during this phase due to asynchronous dispersion of nascent MUPs. Needle EMG is essential: detecting nascent, low-amplitude, polyphasic voluntary MUPs precedes visible clinical movement by several weeks, serving as the first sign of effective motor recovery.

8. Regeneration and Synkinesis Phase (4 to 6 Months)

In severe axonal lesions, aberrant regeneration and collateral sprouting can lead to co-contraction of muscle groups.

  • Indispensable Test: Needle EMG and Blink Reflex R2: Evaluation of synkinesis (e.g., involuntary orbicularis oculi contraction when smiling). Contralateral stimulation on Blink Reflex can demonstrate aberrant interneurons.

9. Late Phase and Reinnervation Failure (> 6 Months)

Chronic assessment to determine permanent sequelae, synkinesis severity, or reinnervation failure.

  • Indispensable Test: Needle EMG (Motor Endplate Viability): In chronic complete paralysis without clinical recovery, needle EMG differentiates between ongoing slow regeneration (presence of nascent MUPs), reinnervation failure with viable muscle (electrical silence with insertional activity preserved), and muscle fibrosis / atrophy (complete absence of insertional activity). This distinction is critical when planning surgical facial reanimation (nerve transfers vs. free muscle flaps).

Summary Table: Prognostic Timeline in Facial Palsy

Phase Timeframe Indispensable Test Primary Objective / Diagnostic Pearl
1. Hyperacute 1–2 days TMS (Motor Cortex) Early predictive value. Distal CMAP and EMG are useless.
2. Initial Drop 3–5 days Needle EMG (in Trauma) Voluntary MUPs rule out transection in trauma. CMAP begins to drop in Bell's.
3. Reflex Pathway Window 6–10 days Blink Reflex (R1/Double Pulse) Evaluates entire pathway. Double pulse reveals hidden R1 in conduction block.
4. Axonal Nadir 11–14 days CMAP (Nasalis) + AVI Gold standard for AVI. Stratifies into Groups 1, 2, and 3.
5. Intermediate Period 15–20 days Blink Re-evaluation + AVI Persistent absent Blink confirms severe loss. Postpone needle to day 21.
6. Denervation Confirmation 21–30 days Needle EMG (Resting Activity) 21-Day Rule: absence of FIB/PSWs has ~100% sensitivity for axonal continuity.
7. Early Reinnervation 1–3 months Needle EMG (Nascent MUPs) Nascent MUPs precede clinical movement by weeks. CMAP is unreliable.
8. Synkinesis & Sprouting 4–6 months Needle EMG + Blink R2 Maps aberrant collateral sprouting and synkinetic co-contraction.
9. Late / Chronic Failure > 6 months Needle EMG (Endplate Viability) Differentiates slow regeneration vs. viable denervated muscle vs. fibrosis.

Frequently Asked Questions (FAQ)

Why is needle EMG contraindicated in idiopathic Bell's palsy before day 21?

In idiopathic Bell's palsy, membrane instability and spontaneous resting activity (fibrillations and positive sharp waves) take approximately 18 to 21 days to fully develop in facial muscles. Performing needle EMG before day 21 yields false-negative results for active denervation. The only exception is direct traumatic or surgical transection, where searching for voluntary MUPs as early as day 3 is indicated to rule out complete nerve division.

Why should CMAP be recorded from the nasalis muscle rather than orbicularis oculi?

Recording CMAP from the nasalis (or nasolabial) muscle is categorical in classical prognostic protocols (such as Uppsala/Stålberg). The nasalis has a well-defined motor point and is anatomically isolated from the masseter muscle, avoiding volume conduction artifacts from trigeminal motor innervation that frequently contaminate orbicularis oculi recordings.

What is the diagnostic significance of double-pulse facilitation on Blink Reflex?

In severe functional conduction block, a single supraorbital electrical stimulus may be subthreshold for triggering an R1 response. Applying paired pulses with a short inter-stimulus interval (~5 ms) induces temporal summation at the brainstem interneurons, revealing an otherwise hidden R1 response and immediately confirming functional axonal continuity.